Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: Modulation by serotonin-3 and nicotinic cholinergic receptors

Sheketha R. Hauser, Gerald A. Deehan, Jamie E. Toalston, Richard Bell, William J. McBride, Zachary Rodd

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Rationale: Alcohol and nicotine co-use can reciprocally promote self-administration and drug-craving/drug-seeking behaviors. To date, the neurocircuitry in which nicotine influences ethanol (EtOH) seeking has not been elucidated. Clinical and preclinical research has suggested that the activation of the mesolimbic dopamine system is involved in the promotion of drug seeking. Alcohol, nicotine, and serotonin-3 (5-HT3) receptors interact within the posterior ventral tegmental area (pVTA) to regulate drug reward. Recently, our laboratory has reported that systemic administration of nicotine can promote context-induced EtOH seeking. Objectives: The goals of the current study were to (1) determine if microinjections of pharmacologically relevant levels of nicotine into the pVTA would enhance EtOH seeking, (2) determine if coadministration of nicotinic cholinergic receptor antagonist (nACh) or 5-HT3 receptor antagonists would block the ability of nicotine microinjected into the pVTA to promote EtOH seeking, and (3) determine if 5-HT3 receptors in the pVTA can modulate EtOH seeking. Results: Nicotine (100 and 200 μM) microinjected into the pVTA enhanced EtOH seeking. Coinfusion with 200 μM mecamylamine (nACh antagonist) or 100 and 200 μM zacopride (5-HT3 receptor antagonist) blocked the observed nicotine enhancement of EtOH seeking. The data also indicated that microinjection of 1 μM CPBG (5-HT3 receptor agonist) promotes context-induced EtOH seeking; conversely, microinjection of 100 and 200 μM zacopride alone reduced context-induced EtOH seeking. Conclusions: Overall, the results show that nicotine-enhanced EtOH-seeking behavior is modulated by 5-HT3 and nACh receptors within the pVTA and that the 5-HT3 receptor system within pVTA may be a potential pharmacological target to inhibit EtOH-seeking behaviors.

Original languageEnglish
Pages (from-to)3745-3755
Number of pages11
JournalPsychopharmacology
Volume231
Issue number18
DOIs
StatePublished - 2014

Fingerprint

Ventral Tegmental Area
Nicotinic Receptors
Cholinergic Receptors
Receptors, Serotonin, 5-HT3
Nicotine
Serotonin
Alcohols
Microinjections
Serotonin 5-HT3 Receptor Antagonists
Serotonin 5-HT3 Receptor Agonists
Drug-Seeking Behavior
Pharmaceutical Preparations
Mecamylamine
Aptitude
Self Administration
Cholinergic Antagonists
Reward
Dopamine
Ethanol
Pharmacology

Keywords

  • Alcohol-preferring P rat
  • Alcohol-seeking behavior
  • Mecamylamine
  • Nicotinic cholinergic receptors
  • Pavlovian Spontaneous Recovery
  • Serotonin-3 receptors
  • Zacopride

ASJC Scopus subject areas

  • Pharmacology

Cite this

Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats : Modulation by serotonin-3 and nicotinic cholinergic receptors. / Hauser, Sheketha R.; Deehan, Gerald A.; Toalston, Jamie E.; Bell, Richard; McBride, William J.; Rodd, Zachary.

In: Psychopharmacology, Vol. 231, No. 18, 2014, p. 3745-3755.

Research output: Contribution to journalArticle

@article{bba5456e28e5409697622ad9426b5490,
title = "Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: Modulation by serotonin-3 and nicotinic cholinergic receptors",
abstract = "Rationale: Alcohol and nicotine co-use can reciprocally promote self-administration and drug-craving/drug-seeking behaviors. To date, the neurocircuitry in which nicotine influences ethanol (EtOH) seeking has not been elucidated. Clinical and preclinical research has suggested that the activation of the mesolimbic dopamine system is involved in the promotion of drug seeking. Alcohol, nicotine, and serotonin-3 (5-HT3) receptors interact within the posterior ventral tegmental area (pVTA) to regulate drug reward. Recently, our laboratory has reported that systemic administration of nicotine can promote context-induced EtOH seeking. Objectives: The goals of the current study were to (1) determine if microinjections of pharmacologically relevant levels of nicotine into the pVTA would enhance EtOH seeking, (2) determine if coadministration of nicotinic cholinergic receptor antagonist (nACh) or 5-HT3 receptor antagonists would block the ability of nicotine microinjected into the pVTA to promote EtOH seeking, and (3) determine if 5-HT3 receptors in the pVTA can modulate EtOH seeking. Results: Nicotine (100 and 200 μM) microinjected into the pVTA enhanced EtOH seeking. Coinfusion with 200 μM mecamylamine (nACh antagonist) or 100 and 200 μM zacopride (5-HT3 receptor antagonist) blocked the observed nicotine enhancement of EtOH seeking. The data also indicated that microinjection of 1 μM CPBG (5-HT3 receptor agonist) promotes context-induced EtOH seeking; conversely, microinjection of 100 and 200 μM zacopride alone reduced context-induced EtOH seeking. Conclusions: Overall, the results show that nicotine-enhanced EtOH-seeking behavior is modulated by 5-HT3 and nACh receptors within the pVTA and that the 5-HT3 receptor system within pVTA may be a potential pharmacological target to inhibit EtOH-seeking behaviors.",
keywords = "Alcohol-preferring P rat, Alcohol-seeking behavior, Mecamylamine, Nicotinic cholinergic receptors, Pavlovian Spontaneous Recovery, Serotonin-3 receptors, Zacopride",
author = "Hauser, {Sheketha R.} and Deehan, {Gerald A.} and Toalston, {Jamie E.} and Richard Bell and McBride, {William J.} and Zachary Rodd",
year = "2014",
doi = "10.1007/s00213-014-3508-3",
language = "English",
volume = "231",
pages = "3745--3755",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "18",

}

TY - JOUR

T1 - Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats

T2 - Modulation by serotonin-3 and nicotinic cholinergic receptors

AU - Hauser, Sheketha R.

AU - Deehan, Gerald A.

AU - Toalston, Jamie E.

AU - Bell, Richard

AU - McBride, William J.

AU - Rodd, Zachary

PY - 2014

Y1 - 2014

N2 - Rationale: Alcohol and nicotine co-use can reciprocally promote self-administration and drug-craving/drug-seeking behaviors. To date, the neurocircuitry in which nicotine influences ethanol (EtOH) seeking has not been elucidated. Clinical and preclinical research has suggested that the activation of the mesolimbic dopamine system is involved in the promotion of drug seeking. Alcohol, nicotine, and serotonin-3 (5-HT3) receptors interact within the posterior ventral tegmental area (pVTA) to regulate drug reward. Recently, our laboratory has reported that systemic administration of nicotine can promote context-induced EtOH seeking. Objectives: The goals of the current study were to (1) determine if microinjections of pharmacologically relevant levels of nicotine into the pVTA would enhance EtOH seeking, (2) determine if coadministration of nicotinic cholinergic receptor antagonist (nACh) or 5-HT3 receptor antagonists would block the ability of nicotine microinjected into the pVTA to promote EtOH seeking, and (3) determine if 5-HT3 receptors in the pVTA can modulate EtOH seeking. Results: Nicotine (100 and 200 μM) microinjected into the pVTA enhanced EtOH seeking. Coinfusion with 200 μM mecamylamine (nACh antagonist) or 100 and 200 μM zacopride (5-HT3 receptor antagonist) blocked the observed nicotine enhancement of EtOH seeking. The data also indicated that microinjection of 1 μM CPBG (5-HT3 receptor agonist) promotes context-induced EtOH seeking; conversely, microinjection of 100 and 200 μM zacopride alone reduced context-induced EtOH seeking. Conclusions: Overall, the results show that nicotine-enhanced EtOH-seeking behavior is modulated by 5-HT3 and nACh receptors within the pVTA and that the 5-HT3 receptor system within pVTA may be a potential pharmacological target to inhibit EtOH-seeking behaviors.

AB - Rationale: Alcohol and nicotine co-use can reciprocally promote self-administration and drug-craving/drug-seeking behaviors. To date, the neurocircuitry in which nicotine influences ethanol (EtOH) seeking has not been elucidated. Clinical and preclinical research has suggested that the activation of the mesolimbic dopamine system is involved in the promotion of drug seeking. Alcohol, nicotine, and serotonin-3 (5-HT3) receptors interact within the posterior ventral tegmental area (pVTA) to regulate drug reward. Recently, our laboratory has reported that systemic administration of nicotine can promote context-induced EtOH seeking. Objectives: The goals of the current study were to (1) determine if microinjections of pharmacologically relevant levels of nicotine into the pVTA would enhance EtOH seeking, (2) determine if coadministration of nicotinic cholinergic receptor antagonist (nACh) or 5-HT3 receptor antagonists would block the ability of nicotine microinjected into the pVTA to promote EtOH seeking, and (3) determine if 5-HT3 receptors in the pVTA can modulate EtOH seeking. Results: Nicotine (100 and 200 μM) microinjected into the pVTA enhanced EtOH seeking. Coinfusion with 200 μM mecamylamine (nACh antagonist) or 100 and 200 μM zacopride (5-HT3 receptor antagonist) blocked the observed nicotine enhancement of EtOH seeking. The data also indicated that microinjection of 1 μM CPBG (5-HT3 receptor agonist) promotes context-induced EtOH seeking; conversely, microinjection of 100 and 200 μM zacopride alone reduced context-induced EtOH seeking. Conclusions: Overall, the results show that nicotine-enhanced EtOH-seeking behavior is modulated by 5-HT3 and nACh receptors within the pVTA and that the 5-HT3 receptor system within pVTA may be a potential pharmacological target to inhibit EtOH-seeking behaviors.

KW - Alcohol-preferring P rat

KW - Alcohol-seeking behavior

KW - Mecamylamine

KW - Nicotinic cholinergic receptors

KW - Pavlovian Spontaneous Recovery

KW - Serotonin-3 receptors

KW - Zacopride

UR - http://www.scopus.com/inward/record.url?scp=84906934894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906934894&partnerID=8YFLogxK

U2 - 10.1007/s00213-014-3508-3

DO - 10.1007/s00213-014-3508-3

M3 - Article

C2 - 24599396

AN - SCOPUS:84906934894

VL - 231

SP - 3745

EP - 3755

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 18

ER -